<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Infect Dis Model</span><span class="iso-abbrev" title="iso-abbrev">Infect Dis Model</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Infectious Disease Modelling</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">2468-2152</span><span class="issn-epub" tagx="issn" title="issn-epub">2468-0427</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">KeAi Publishing</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7326430">7326430</a></span><span class="publisher-id" title="publisher-id">S2468-0427(20)30017-8</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.idm.2020.06.001">10.1016/j.idm.2020.06.001</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Special issue on Modelling and Forecasting the 2019 Novel Coronavirus (2019-nCoV) Transmission; Edited by Prof. Carlos Castillo-Chavez, Prof. Gerardo Chowell-Puente, Prof. Ping Yan, Prof. Jianhong Wu</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Pushing past the tipping points in containment trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics: A simple arithmetic rationale for crushing the curve instead of merely flattening it</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Killeen</span><span class="given-names" tagx="given-names" title="given-names">Gerry F.</span></span><span class="email" tagx="email" title="email">gerard.killeen@ucc.ie</span></span><span class="citation_author_institution" id="aff1">[], </span></div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-6-6</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2020</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-6-6</span></span><span class="volume" tagx="volume" title="volume">5</span><span class="fpage" tagx="fpage" title="fpage">362</span><span class="lpage" tagx="lpage" title="lpage">365</span><span class="history" title="history"><span class="received" title="received">received: 2020-5-21</span><span class="accepted" title="accepted">accepted: 2020-6-17</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>Countries with ambitious national strategies to <i>crush the curve</i> of their Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) epidemic trajectories include China, Korea, Japan, Taiwan, New Zealand and Australia. However, the United States and many hard-hit European countries, like Ireland, Italy, Spain, France and the United Kingdom, currently appear content to merely <i>flatten the curve</i> of their epidemic trajectories so that transmission persists at rates their critical care services can cope with. Here I present a simple set of arithmetic modelling analyses that are accessible to non-specialists and explain why preferable <i>crush the curve</i> strategies, to eliminate transmission within months, would require only a modest amount of additional containment effort relative to the tipping point targeted by <i>flatten the curve</i> strategies, which allow epidemics to persist at supposedly steady, manageable levels for years, decades or even indefinitely.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Coronavirus</div> <div class="kwd" title="kwd">
COVID</div> <div class="kwd" title="kwd">
SARS2</div> <div class="kwd" title="kwd">
Severe acute respiratory syndrome coronavirus 2</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
Model</div> <div class="kwd" title="kwd">
Epidemiology</div> <div class="kwd" title="kwd">
Outbreak</div> <div class="kwd" title="kwd">
Zoonosis</div> <div class="kwd" title="kwd">
Emerging infection</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="kwd" title="kwd">
SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2</div> </div> </div> <p id="misc0010">Handling editor: Jianhong Wu</p> </div> <div class="body" title="body"> <div class="maintext" title="sec"> <div class="title" tagx="title" title="title">
Main text</div> <p id="p0010">Most cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relatively mild or even asymptomatic (<a href="#bib6">Gandhi, Yokoe, &amp;amp; Havlir, 2020</a>; <a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>), and transmission can occur through such subtle mechanisms as droplets generated while speaking (<a href="#bib1">Anfinrud, Stadnytskyi, Bax, &amp;amp; Bax, 2020</a>) and persistence on contaminated surfaces (<a href="#bib2">van Doremalen et al., 2020</a>). Reactive containment interventions against SARS-CoV-2, based on testing and contact tracing, are therefore unlikely to succeed as a stand-alone containment measures (<a href="#bib6">Gandhi, Yokoe, &amp;amp; Havlir, 2020</a>; <a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>). Furthermore, it remains to be seen whether any sufficiently effective new vaccines or drugs can be developed, evaluated and made available globally in sufficient quantities soon enough to avert the worst consequences of the ongoing SARS-CoV-2 pandemic (<a href="#bib10">Rubin, Baden, &amp;amp; Morrissey, 2020a</a>). In the meantime, the only effective intervention options available to governments are various presumptive social distancing, hygiene and quarantine measures, enforced variations of which are often referred to as <i>lock down</i>.</p> <p id="p0015">However, different countries appear to be applying these behavioural interventions to achieve quite distinct targets for their epidemic trajectories (<a href="#bib11">Rubin, Baden, &amp;amp; Morrissey, 2020b</a>). Examples of countries with ambitious strategies to <i>crush the curve</i> (<a href="#bib5">Fineberg, 2020</a>) of their epidemic trajectories, to promptly eliminate SARS-CoV-2 transmission at national level, include China, Korea, Japan, Taiwan, New Zealand and Australia. In stark contrast, the United States and many hard-hit European countries, like Ireland, Italy, Spain, France and the United Kingdom, currently appear content to merely <i>flatten the curve</i> of their epidemic trajectories so that transmission persists at rates their critical care services can cope with. Here I present a simple set of arithmetic modelling analyses that explain why preferable <i>crush the curve</i> strategies, to eliminate transmission within months, would require only a modest amount of additional containment effort relative to the tipping point targeted by <i>flatten the curve</i> strategies, which allow epidemics to persist at supposedly steady, manageable levels for years, decades or even indefinitely (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>; <a href="#bib8">Kissler, Tedijanto, Goldstein, Grad, &amp;amp; Lipsitch, 2020</a>).</p> <p id="p0020">Much can be learned by simply examining the targets for these two alternative strategies, relative to the starting point before interventions were introduced, expressed in terms of the reproductive number of the virus (<i>R</i>) or number of new infections arising from any initial infection over its full duration. An epidemic curve which has been exactly flattened, so that the rate of incidence of new infections remains constant (<i>R</i><sub><i>0</i></sub> = 1.0), represents the tipping point in efforts to contain SARS-CoV-2. Once the reproductive number has been pushed below this critical threshold, even modest further reductions achieve a snowball effect that crushes the epidemic curve by progressively accelerating progress towards elimination of local transmission (<a href="#fig1">Fig. 1</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p><b>The effects of varying levels of containment effectiveness upon the expected subsequent trajectories of a SARS-CoV-2 epidemic.</b> It was assumed that the epidemic had reached an incidence rate of 10,000 new infections per week at the point when a suite of presumptive, population-wide preventative behavioural interventions (often referred to as <i>lock down</i> if enforced) were introduced, with an initial pre-intervention reproductive number of 4 new infections per existing infection (<i>R</i><sub><i>0</i></sub> = 4.0). <b>A</b> and <b>D</b>: Controlled reproductive numbers (<i>R</i><sub><i>c</i></sub>) expressed as a function of either (<b>A</b>) overall reduction of transmission rate (1-<i>R</i><sub><i>c</i></sub>/<i>R</i><sub><i>0</i></sub>) or (<b>D</b>) the mean effective protective coverage of individuals with interventions to prevent exposure behaviours (<i>C</i><sub><i>p</i></sub>). <b>B</b>, <b>C</b>, <b>D</b> and <b>E</b>: Controlled reproduction numbers (<i>R</i><sub><i>c</i></sub>) and incidence rate trajectories expressed as functions of either (<b>B</b> and <b>C)</b> overall reduction of transmission rate (1-<i>R</i><sub><i>c</i></sub>/<i>R</i><sub><i>0</i></sub>) or (<b>E</b> and <b>F)</b> effective protective coverage of individuals with interventions to prevent exposure behaviours (<i>C</i><sub><i>p</i></sub>). Panels <b>C</b> and <b>F</b> are identical to panels <b>B</b> and <b>E</b>, respectively, except that the vertical axis is expressed on a logarithmic scale.</p>   </div> <p /> <p id="p0025">For example, if we assume an approximate median between the most conservative (lowest) and insightful (highest) estimates for the reproductive number of the virus under the unconstrained conditions before interventions were introduced (<i>R</i><sub><i>0</i></sub>) at the outset of well-documented outbreaks, a baseline value of 4.0 seems as reasonable as any (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>). From this assumed starting point, a country that contains its epidemic sufficiently to <i>flatten the curve</i> to a plateau, so that the rate of incidence of new infections remains constant, would have achieved a controlled reproductive number (<i>R</i><sub><i>c</i></sub>) of exactly 1.0 (<a href="#fig1">Fig. 1</a>A). Relative to where that country started, this minimum containment level required to prevent the epidemic from growing further would represent a 75% reduction of transmission (<a href="#fig1">Fig. 1</a>A). Countries like Ireland, France, Spain, Italy and the United Kingdom, where daily incidence rates are now slowly falling (<i>Rc</i> &amp;lt; 1.0), so their epidemics could slowly fizzle away if current measures were maintained, may well have achieved 80% suppression of transmission (<a href="#fig1">Fig. 1</a>B and C). If sustained, current measures in these countries could be expected to see their incidence rates shrink by 98% but not disappear over the course of a year (<a href="#fig1">Fig. 1</a>B and C).</p> <p id="p0030">While this is a considerable achievement, it begs the question why these countries would not build upon their successes by pushing even just a little further past this crucial tipping point? Why not just further fine-tune their epidemic responses to steepen the downslope they now find themselves on and then pursue the sequential goals of elimination and exclusion? Even just a further 10% reduction of transmission may be reasonably expected to result in an overall transmission reduction of 85% and an epidemic that would contract by 40% (<i>R</i><sub><i>c</i></sub> = 0.6, <a href="#fig1">Fig. 1</a>A) every 3 weeks (Approximate mean duration of infection (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>)) before petering out after little more than a year (<a href="#fig1">Fig. 1</a>B and C). Squeeze transmission down by just another 5% overall (90% reduction, <i>Rc</i> = 0.4, <a href="#fig1">Fig. 1</a>A) and local transmission may collapse within 30 weeks (<a href="#fig1">Fig. 1</a>B and C).</p> <p id="p0035">While these levels of transmission suppression may sound very high, several countries (notably China (<a href="#bib13">Tang et al., 2020</a>), which was hit first and without warning at the outset) have achieved controlled reproductive numbers and incidence shrinkage rates in this approximate range, so they are beginning to approach elimination targets. Furthermore, such impressive reductions of transmission rate and relatively rapid escape trajectories from self-sustaining local transmission may be far easier to rationalize in simple arithmetic terms by considering two important, intuitive and encouraging non-linearities of pathogen outbreak and containment dynamics: (1) Transmission requires exposure behaviours by two individuals, so transmission varies in proportion to the square of the relative rates of those preventable exposure behaviours, and (2) Even modest acceleration of proportional decay rates can dramatically curtail the length of time it takes for them to approach zero.</p> <p id="p0040">Transmission from one individual to another requires exposure behaviours by two people who interact through direct contact or through shared spaces, surfaces and objects. Transmission rate is therefore proportional to the product of their individual exposure behaviour rates, which in turn depends on limitations of intervention coverage and effectiveness once containment measures are introduced. Correspondingly, the reproductive rate achieved by such control measures may be calculated as a simple squared function of the gap in the population mean effective protective coverage (<i>C</i><sub><i>p</i></sub>) for a preventative intervention suite: </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">Eq. 1</span><i>R</i><sub><i>c</i></sub> = <i>R</i><sub><i>0</i></sub> (1 - <i>C</i><sub><i>p</i></sub>)<sup>2</sup></div>where effective protective coverage is the product of the population mean compliance coverage (<i>C</i>) and effective personal protection (<i>ρ</i>) achieved by compliant individuals (<i>C</i><sub><i>p</i></sub> = <i>ρ C</i>) (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>). This intuitively non-linear relationship indicates that proportional impacts upon transmission may be reasonably expected to exceed effective protective coverage (<a href="#fig1">Fig. 1</a>D), so thresholds for flattening or crushing the epidemic curve may be achieved more readily than would otherwise be envisaged (<a href="#fig1">Fig. 1</a>E and F). When intervention effectiveness is expressed as the mean proportional reduction of individual exposure behaviours, a steady-state flattened curve is achieved at an effective protective coverage of only 50% (<a href="#fig1">Fig. 1</a>D, E and F). Even very modest further reductions beyond this threshold result in remarkably steep expected downslopes for epidemic contraction (<a href="#fig1">Fig. 1</a>E and F). For example, incidence rates are expected to drop by a third every three weeks at an effective protective coverage of 60% (<i>R</i><sub><i>0</i></sub> = 0.64, <a href="#fig1">Fig. 1</a>D) and by almost two thirds (<i>R</i><sub><i>0</i></sub> = 0.36) at an effective protective coverage of 70% (<a href="#fig1">Fig. 1</a>E and F).<p /> <p id="p0045">Many non-specialists are familiar with the explosive dynamics of exponential growth, reflected in the steep upward trajectories expected for 5% shortfalls relative to <i>flatten the curve</i> containment targets (<a href="#fig1">Fig. 1</a>B, C, E and F). However, the equally important implications of non-linearities in exponential decay curves are less widely appreciated. Analogous to eating a cake in proportion to its remaining size, it takes a long time to get down to the last crumbs if one eats a third, and then a third of the remaining two thirds, and so on. By comparison, consuming two thirds the first time, and then two thirds of the remaining one third the second time, reduces the cake much faster. In fact, the remaining fraction of the hypothetical cake will be four times smaller (1/9 versus 4/9) after only removing two slices and the difference in relative size grows rapidly as these two trajectories proceed. The same simple arithmetic rules apply to epidemic containment, so the expected trajectories for 60% and 70% effective protective coverage in <a href="#fig1">Fig. 1</a>E and F resemble those for our hypothetical cake. Correspondingly, these two modestly ambitious containment levels, which differ by only 10% in terms of effective protective coverage, need to be maintained for very different periods before the last cases are expected to occur. While lowering the incidence rate from 10,000 to only 1 case per week is expected to take 60 weeks at 60% effective protective coverage, the same near-elimination threshold would be reached after only 27 weeks at 70% effective protective coverage (<a href="#fig1">Fig. 1</a>E and F). At 80% effective protective coverage, only 15 weeks are required to approach elimination, and while the "10 weeks to crush the curve" hypothesis (<a href="#bib5">Fineberg, 2020</a>) appears questionably optimistic, it might nevertheless be plausible if 85% protective coverage could be achieved (<a href="#fig1">Fig. 1</a>E and F).</p> <p id="p0050">Furthermore, the rapid growth of expected incidence rates for <i>flatten the curve</i> strategies that fall only 5% short of their targets (<a href="#fig1">Fig. 1</a>B, C, E and F) underlines the fundamental dangers of this approach. It also highlights the fact that there is very little room for relaxing current restrictions in many countries where they have proven barely sufficient to contain the epidemic and begin slowly shrinking it (<a href="#bib12">Saez, Tobias, Varga, &amp;amp; Barcelo, 2020</a>). Considering how easily and rapidly epidemics may spiral out of control when restrictions are relaxed or viral reproduction surges for a variety of other reasons (<a href="#fig1">Fig. 1</a>B, C, E and F), it is vital to remember that tipping points tip in both directions and are therefore dangerous places to linger. Deliberately planning to establish near-steady-state equilibria for epidemics with naturally volatile dynamics that are difficult to predict (<a href="#bib8">Kissler, Tedijanto, Goldstein, Grad, &amp;amp; Lipsitch, 2020</a>) is risky at best. Additional risks of allowing SARS-CoV-2 transmission to continue include indefinite persistence among humans through unstable endemic transmission (<a href="#bib8">Kissler, Tedijanto, Goldstein, Grad, &amp;amp; Lipsitch, 2020</a>), establishment of zoonotic reservoirs, and rapid evolution of a large viral population into new forms that could be even more difficult to contain.</p> <p id="p0055">The ambitious containment and exclusion requirements of <i>crush the curve</i> strategies are obviously substantive undertakings. Success will require meticulous closure of remaining gaps in preventative intervention coverage, as well as comprehensive containment of case importation through travel and trade (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>). However, many tractable opportunities remain to be exploited for closing the various loopholes in intervention coverage and effectiveness that allow residual transmission to persist through essential workers, goods and services of all kinds (<a href="#bib7">Killeen &amp;amp; Kiware, 2020</a>). And many encouraging precedents exist for certifying countries as free from infection with veterinary pathogens like swine fever (<a href="#bib9">Martin, Cameron, Barfod, Sergeant, &amp;amp; Greiner, 2007</a>) or human pathogens like malaria (<a href="#bib3">Feachem et al., 2019</a>). It is also encouraging that viral outbreaks of Ebola in 2014 and 2018, Severe Acute Respiratory Syndrome in 2003 and Middle East Respiratory Syndrome in 2012 all threated to become larger pandemics but were successfully contained and eliminated. However, the most convincing reason to be optimistic about SARS-CoV-2 is that several countries in Asia and the Pacific that have already crushed their epidemic curves are well on the way to elimination and exclusion endpoints.</p> <p id="p0060">More to the point, there appears to be no other safe and sensible option going forward that doesn’t necessitate extending most existing restrictions (<a href="#fig1">Fig. 1</a>) and their inevitable socioeconomic consequences for years, decades or even indefinitely (<a href="#bib4">Ferguson et al., 2020</a>; <a href="#bib8">Kissler, Tedijanto, Goldstein, Grad, &amp;amp; Lipsitch, 2020</a>). And as in any competitive sport, playing a long drawn out defensive game against an unpredictable, fast-moving, adaptable and unrelenting opponent is asking for trouble.</p> </div> <div class="authorcontribution" title="sec"> <div class="title" tagx="title" title="title">
Author contribution</div> <p id="p0065">GFK is the sole contributor to this article.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Declaration of competing interest</div> <p id="p0070">The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bib2" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Doremalen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bushmaker</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morris</span><span class="given-names" tagx="given-names" title="given-names">D.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Holbrook</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gamble</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Williamson</span><span class="given-names" tagx="given-names" title="given-names">B.N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="issue" tagx="issue" title="issue">16</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1564</span><span class="lpage" tagx="lpage" title="lpage">1567</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMc2004973">10.1056/NEJMc2004973</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32182409">32182409</a></span></span></li> <li tag="ref"><a name="bib1" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anfinrud</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stadnytskyi</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bax</span><span class="given-names" tagx="given-names" title="given-names">C.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bax</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Visualizing speech-generated oral fluid droplets with laser light scattering</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">2061</span><span class="lpage" tagx="lpage" title="lpage">2063</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMc2007800">10.1056/NEJMc2007800</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32294341">32294341</a></span></span></li> <li tag="ref"><a name="bib3" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feachem</span><span class="given-names" tagx="given-names" title="given-names">R.G.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akbari</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bertozzi-Villa</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhatt</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Binka</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Malaria eradication within a generation: Ambitious, achievable, and necessary</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">394</span><span class="issue" tagx="issue" title="issue">10203</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">1056</span><span class="lpage" tagx="lpage" title="lpage">1112</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(19)31139-0">10.1016/S0140-6736(19)31139-0</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31511196">31511196</a></span></span></li> <li tag="ref"><a name="bib4" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferguson</span><span class="given-names" tagx="given-names" title="given-names">N.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Laydon</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nedjati-Gilani</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imai</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ainslie</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baguelin</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand</span><span class="source" tagx="source" title="source">WHO collaborating centre for infectious disease modelling, MRC centre for global infectious disease analysis</span><span class="year" tagx="year" title="year">2020</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Abdul Latif Jameel Institute for Disease and Emergency Analytics &amp;amp; Imperial College London</span><span class="fpage" tagx="fpage" title="fpage">20</span></span></li> <li tag="ref"><a name="bib5" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fineberg</span><span class="given-names" tagx="given-names" title="given-names">H.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Ten weeks to crush the curve</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="issue" tagx="issue" title="issue">17</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e37</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMe2007263">10.1056/NEJMe2007263</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32237671">32237671</a></span></span></li> <li tag="ref"><a name="bib6" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gandhi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yokoe</span><span class="given-names" tagx="given-names" title="given-names">D.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Havlir</span><span class="given-names" tagx="given-names" title="given-names">D.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Asymptomatic transmission, the Achilles’ Heel of current strategies to control covid-19</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">2158</span><span class="lpage" tagx="lpage" title="lpage">2160</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMe2009758">10.1056/NEJMe2009758</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32329972">32329972</a></span></span></li> <li tag="ref"><a name="bib7" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Killeen</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kiware</span><span class="given-names" tagx="given-names" title="given-names">S.S.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 Novel Coronavirus</span><span class="year" tagx="year" title="year">2020</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Infectious Disease Modelling. In press</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.04.15.20066845">10.1101/2020.04.15.20066845</a></span></span></li> <li tag="ref"><a name="bib8" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kissler</span><span class="given-names" tagx="given-names" title="given-names">S.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tedijanto</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goldstein</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grad</span><span class="given-names" tagx="given-names" title="given-names">Y.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipsitch</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</span><span class="source" tagx="source" title="source">Science</span><span class="volume" tagx="volume" title="volume">368</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">860</span><span class="lpage" tagx="lpage" title="lpage">868</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.abb5793">10.1126/science.abb5793</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32291278">32291278</a></span></span></li> <li tag="ref"><a name="bib9" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">P.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cameron</span><span class="given-names" tagx="given-names" title="given-names">A.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barfod</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sergeant</span><span class="given-names" tagx="given-names" title="given-names">E.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Greiner</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Demonstrating freedom from disease using multiple complex data sources 2: Case study--classical swine fever in Denmark</span><span class="source" tagx="source" title="source">Preventive Veterinary Medicine</span><span class="volume" tagx="volume" title="volume">79</span><span class="issue" tagx="issue" title="issue">2-4</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">98</span><span class="lpage" tagx="lpage" title="lpage">115</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.prevetmed.2006.09.007">10.1016/j.prevetmed.2006.09.007</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17239459">17239459</a></span></span></li> <li tag="ref"><a name="bib10" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rubin</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baden</span><span class="given-names" tagx="given-names" title="given-names">L.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morrissey</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Audio interview: Approaches to covid-19 vaccines and antivirals</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="issue" tagx="issue" title="issue">16</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e58</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMe2012889">10.1056/NEJMe2012889</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32320592">32320592</a></span></span></li> <li tag="ref"><a name="bib11" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rubin</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baden</span><span class="given-names" tagx="given-names" title="given-names">L.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morrissey</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Audio interview: Loosening covid-19 restrictions</span><span class="source" tagx="source" title="source">New England Journal of Medicine</span><span class="volume" tagx="volume" title="volume">382</span><span class="issue" tagx="issue" title="issue">18</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e67</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMe2014793">10.1056/NEJMe2014793</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32348666">32348666</a></span></span></li> <li tag="ref"><a name="bib12" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saez</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tobias</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Varga</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barcelo</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effectiveness of the measures to flatten the epidemic curve of COVID-19. The case of Spain</span><span class="source" tagx="source" title="source">The Science of the Total Environment</span><span class="volume" tagx="volume" title="volume">727</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">138761</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.scitotenv.2020.138761">10.1016/j.scitotenv.2020.138761</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32330703">32330703</a></span></span></li> <li tag="ref"><a name="bib13" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bragazzi</span><span class="given-names" tagx="given-names" title="given-names">N.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China</span><span class="source" tagx="source" title="source">International Journal of Infectious Diseases</span><span class="volume" tagx="volume" title="volume">95</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">288</span><span class="lpage" tagx="lpage" title="lpage">293</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijid.2020.03.018">10.1016/j.ijid.2020.03.018</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171948">32171948</a></span></span></li> </ul> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>This study was supported by an AXA Research Chair award to the author, kindly provided by the AXA Research Fund, and by </p><div class="funding-source" title="funding-source">
Irish Aid, Deparment of Foreign Affairs and Trade, Government of Ireland</div> through the Embassy of Ireland in Tanzania (Award number IA-TAN/2020/086).<p /> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p id="ntpara0010">Peer review under responsibility of KeAi Communications Co., Ltd.</p> </div> </div> </div>  </body></html>